low risk prostate cancer

September 23, 2019

Prolaris Helps to ID Prostate Cancer Patients Suited for Active Surveillance, Study Says

News

Prolaris, a genetic test developed by Myriad Genetics to help predict the aggressiveness of prostate cancer, can accurately identify prostate cancer patients with low-risk disease who may safely opt for ... Read more

March 18, 2019

Some PC Patients Can Safely Receive Short but Intense Course of Radiation

News

Stereotactic body radiotherapy (SBRT), which delivers higher doses of radiation over a significantly shorter period of time, can be safely given to men with low- or intermediate-risk prostate cancer with similar ... Read more

January 14, 2019

Prostate Cancer Scoring Method May Not Accurately Predict Outcomes in Black Men, Study Suggests

News

Black men diagnosed with low-risk prostate cancer are two times more likely to actually have a more aggressive, fatal form of the disease than those of other races, suggesting that ... Read more

December 13, 2018

10-Year Survival of Young Low- and Intermediate-risk Prostate Cancer Patients Better with Radiation than Surgery

News

Radiation therapy approaches — including brachytherapy and external beam radiation therapy (EBRT) — lead to better 10-year survival rates than prostate surgery in young patients with low- and intermediate-risk prostate ... Read more

November 1, 2018

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

News

Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as the ... Read more

August 13, 2018August 14, 2018

3 in 4 Men with Slow-growing Prostate Cancer Fail to Get Appropriate Follow-up, Study Finds

News

Nearly three-quarters of men with slow-growing prostate cancer who decide on active surveillance are not receiving the appropriate follow-up and might be missing signs of tumor worsening, according to a recent ... Read more

July 2, 2018

TOOKAD Reduced Disease Worsening in Low-risk Prostate Cancer Patients After 4 Years, Study Found

News

Steba Biotech‘s TOOKAD treatment significantly reduces overall disease progression in men with low-risk prostate cancer, eliminating the need for most low-risk patients to undergo radical therapy, according to four-year follow-up ... Read more

June 4, 2018

Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show

News

Prostate cancer patients who undergo a nonsurgical procedure to remove part of their prostate gland — using a kind of photodynamic therapy targeting the blood vessels — fare better in ... Read more

March 12, 2018March 12, 2018

PSA Test in Asymptomatic Men Detects Low-risk Prostate Cancer but Doesn’t Save Lives, Trial Shows

News

Using a single PSA test to screen men with no symptoms increases detection of low-risk prostate cancer, but does not reduce mortality, results from large U.K. clinical trial show. The ... Read more

March 5, 2018March 5, 2018

Fewer PSA Tests May Benefit Older, Low-Risk Prostate Cancer Survivors, Study Says

News

A new study suggests that older patients who survived prostate cancer with a low risk of recurrence could benefit from fewer prostate cancer antigen (PSA) tests, as they are more ... Read more